Multi-directional Changes in 8-OHdG Concentration in Saliva during HER2 Expression in Breast Cancer

Main Article Content

E.I. Dyachenko
E.V. Pahalkova
E.A. Sarf
L.V. Bel`skaya

Abstract

The purpose of this work was to evaluate changes in the structure of 8-OHdG in saliva in patients with breast cancer depending on molecular biological subtypes. The findings show that decreased salivary 8-OHdG concentrations in the HER2-positive group rapidly correlated with decreased cell differentiation and high Ki-67 levels, reflecting the aggressive nature of the tumor disease and poor survival prognosis. Thus, the presence of high levels of 8-OHdG in the oral cavity may lead to the development of the role of a biological marker of the HER2-positive group with a poor prognosis of breast cancer and can be used as an additional method of diagnosis, patient condition and response to therapy.

Article Details

How to Cite
Dyachenko, E., Pahalkova, E., Sarf, E., & Bel`skaya, L. (2024). Multi-directional Changes in 8-OHdG Concentration in Saliva during HER2 Expression in Breast Cancer. Biomedical Chemistry: Research and Methods, 7(3), e00236. https://doi.org/10.18097/BMCRM00236
Section
CLINICAL STUDIES

References

  1. Hirano, T. (2008) Repair system of 7,8-dihydro-8-oxoguanine as a defense line against carcinogenesis. J. Radiat. Res., 49(4), 329–440. DOI
  2. Sova, H., Jukkola-Vuorinen, A., Puistola, U., Kauppila, S., Karihtala, P. (2010) 8-Hydroxydeoxyguanosine: Anew potential independent prognostic factor in breast cancer. Br. J. Cancer, 102(6), 1018–1023. DOI
  3. Vulimiri, S.V., Wu, X., Baer-Dubowska, W., de Andrade, M., Detry, M., Spitz, M.R., DiGiovanni, J. (2000) Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo-2′-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol. Carcinog., 27(1), 34–46. DOI
  4. Nishigori, C., Arima, Y., Matsumura, Y., Matsui, M., Miyachi, Y. (2005) Impaired removal of 8-hydroxydeoxyguanosine induced by UVB radiation in naevoid basal cell carcinoma syndrome cells. Br. J. Dermatol., 153(Suppl 2), 52–56. DOI
  5. Kaczmarek, P., Bіaszczyk, J., Fijaіkowski, P., Sierakowska-Fijaіek, A., Niemirowicz, J., Kasprzak, A., Baj, Z. (2005) Analiza stezenia 8-hydroksy-2′-deoxyguanozyny w moczu chorych na powierzchownego raka pecherza moczowego leczonych zawiesina pratka BCG [Assessment of 8-hydroxy-2′-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation]. Polski Merkuriusz Lekarski, 19(112), 526–528.
  6. Romano, G., Sgambato, A., Mancini, R., Capelli, G., Giovagnoli, M.R., Flamini, G., Boninsegna, A., Vecchione, A., Cittadini, A. (2000) 8-Hydroxy-2′-deoxyguanosine in cervical cells: Correlation with grade of dysplasia and human papillomavirus infection. Carcinogenesis, 21, 1143–1147.
  7. Miyake, H., Hara, I., Kamidono, S., Eto, H. (2004) Oxidative DNA damage in patients with prostate cancer and its response to treatment. J. Urol., 171(4), 1533–1536. DOI
  8. Farinati, F., Cardin, R., Bortolami, M., Nitti, D., Basso, D., de Bernard, M., Cassaro, M., Sergio, A., Rugge, M. (2008) Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int. J. Cancer., 123(1), 51–55. DOI
  9. Schafer, Z.T., Grassian, A.R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H.Y., Gao, S., Puigserver, P., Brugge, J.S. (2009) Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature, 461(7260), 109–113. DOI
  10. Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., Zhang, D.D. (2009) Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell., 34(6), 663–673. DOI
  11. Tai, D.J., Jin, W.S., Wu, C.S., Si, H.W., Cao, X.D., Guo, A.J., Chang, J.C. (2012) Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells. Exp. Ther. Med., 4(2), 291–296. DOI
  12. Bel’skaya, L.V., Sarf, E.A., Solomatin,D.V. (2024) Free salivary amino acid profile in breast cancer: Clinicopathological and molecular biological Features. Curr. Issues Mol. Biol., 46(6), 5614–5631. DOI